NY-DILIGENT
17.9.2020 16:19:10 CEST | Business Wire | Press release
Diligent Corporation, a leading modern governance company used by nearly 700,000 board directors and leaders, today announced additional partnerships to enhance its Modern Leadership initiative, which provides senior leaders with the resources, insights, partnerships, and technology needed to further catalyze diversity and modernize governance in their organizations. To propel Modern Leadership forward, Diligent is partnering with an additional 11 private equity firms – 21 in total – and an additional four search firms, including Heidrick & Struggles and Egon Zehnder, joining founding partner Spencer Stuart. These partners commit to posting open board opportunities specifically for diverse candidates within the Diligent Director Network.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200917005593/en/
The initiative aims to bring transparency to director recruitment systems and open the process to diverse networks. By working directly with decision-makers instrumental to disrupting the status quo, Diligent, through the Modern Leadership initiative, is leveraging data and technology to drive diversity at the highest levels of the world’s leading organizations with an emphasis on increasing opportunities and placements for historically underrepresented groups.
“Our goal with Modern Leadership is to provide companies with access to the most diverse network of talent by creating transparency into the executive and board recruitment processes,” said Brian Stafford, CEO of Diligent. “What we’ve learned over the years is that to diversify boards it is necessary to go outside traditional professional circles. In many ways we have a networking problem, not a pipeline problem. Modern Leadership solves this by offering a new level of access and transparency.”
Launched in June, the Modern Leadership initiative has seen tremendous success, approaching 100 open board roles that will be filled by diverse candidates. As part of the initiative, Diligent’s Director Network – the world’s largest and most diverse community of board-ready talent – now boasts more than 500 individuals primed for board roles as nominated by sitting public company directors. Together, Modern Leadership and the Diligent Director Network are changing the way boards identify and recruit new talent, making the board selection process more transparent than ever.
To bolster the existing momentum surrounding Modern Leadership , today, Diligent is:
- Teaming up with an additional 11 private equity firms to open board roles for diverse director candidates. The latest private equity firms to partner with Diligent are TPG, Francisco Partners, ICV Partners, GI Partners, New Mountain Capital, The Jordan Company, The Riverside Company, Palladium Equity Partners, Argand Partners, Sumeru Equity Partners and Blue Point Capital Partners. With these additions, the Modern Leadership initiative now encompasses a total of 21 private equity firms.
- Tapping additional search firms to more widely disseminate and share searches in a way that has not previously been done. In addition to a continued partnership with Spencer Stuart, the latest firms to partner with Diligent include Egon Zehnder, Heidrick & Struggles, and SPMB.
- Collaborating with the National Association of Investment Companies and the American Investment Council members to further champion the need for board diversity within leading private equity firms.
- Partnering with 10 additional organizations that are dedicated to diversifying executives and directors, including Athena Alliance, BlackNorth, Sigma Pi Phi’s Blacks on Corporate Boards Committee, and The Toigo Foundation. Through these partnerships, Diligent is expanding its Director Network to include members and affiliates of 15 organizations focused on leadership diversity.
“TPG is pleased to join Diligent’s Modern Leadership initiative in support of their vision to build a dynamic and transparent marketplace for diverse talent,” said Ben Holzemer, Partner and Head of Human Capital at TPG Capital. “Over the past few years, we’ve been focused on increasing the gender, racial, and ethnic diversity of our own portfolio of company boards, and have since partnered with companies who have appointed more than 80 women directors. We look forward to leveraging Diligent’s platform to build on this exciting work, while sharing referrals to the many talented diverse executives we have been fortunate to be introduced to through our own extensive network.”
“At Egon Zehnder, we believe in leadership for a better world,” said Ashley Summerfield, Managing Partner of Egon Zehnder’s Board Practice. “We are convinced that involving an ever-more diverse range of talented individuals in the board rooms of major corporations will have a positive effect on the performance, culture, and stakeholders of organizations around the world. We are honored to be part of this initiative led by Diligent and its other partners.”
“To see real change in diverse representation – starting at the top – boards and organizations have to shift their paradigms, change their definitions, and their approach to D&I,” said Lyndon Taylor, Managing Partner of the Diversity & Inclusion Practice at Heidrick & Struggles. “We are excited to be part of Diligent’s Modern Leadership initiative and to help leaders build the best diverse teams possible.”
“There are tremendous opportunities to shift the narrative on board diversity and provide a way for organizations to connect with talent via the Modern Leadership initiative. We’re thrilled to be a part of this effort in support of members of the Toigo organization and our broader network who have aspiration and expertise to serve on boards,” said Nancy Sims, President of the Toigo Foundation.
The initial Modern Leadership partners consist of 10 leading private equity firms, including Insight Partners, Clearlake Capital, Vista Equity Partners, Hellman & Friedman, Hg, Genstar Capital, TA Associates, K1 Investment Management, Aurora Capital Partners, and Grain Management, to identify and create board roles for diverse director candidates. The launch also included a partnership with executive search and leadership advisory firm Spencer Stuart to promote and create opportunities.
About Diligent Corporation
Diligent Corporation is the pioneer of modern governance, empowering leaders to turn effective governance into a competitive advantage. Leveraging unparalleled insights from a team of industry innovators, as well as highly secure, integrated SaaS technologies, Diligent’s industry-leading suite of solutions changes how work gets done at the executive and board levels. Leaders rely on Diligent to drive accountability and transparency, while addressing stakeholder and shareholder priorities. Its applications also help streamline the day-to-day work of board management and committees, and support collaboration and secure information sharing. Designed for both public and private sector organizations, Diligent is helping to usher in a new era of modern governance.
The largest global network of directors and executives, Diligent is relied on by more than 19,000 organizations and nearly 700,000 leaders in more than 90 countries. With an eye towards inclusivity and accessibility, Diligent serves some of the largest public governing bodies, including more than 50% of the Fortune 1000, 70% of the FTSE 100, and 65% of the ASX.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200917005593/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
